InvestorsHub Logo
Followers 0
Posts 167
Boards Moderated 0
Alias Born 07/21/2013

Re: Biobillionair post# 76197

Thursday, 03/31/2016 12:56:57 PM

Thursday, March 31, 2016 12:56:57 PM

Post# of 425688
Three things.

1) Why would the stock price change now as the company has informed investors especially shorts that they still have six months to play before some clarification on RI?

2) Lets entertain for a minute your idea for them to litigate SPA rescinding with the FDA. I would think and correct me if I am wrong with the interim analysis they could finish the appealing process within the FDA all the way up to the director of the FDA before they would litigate in court, or did they sign off on that with the FDA? I thought they reserved there right to continue the appeals process with the FDA but I can't remember? Does RI interim analysis continue decision by the DMC allow there argument to be stronger for this appeals process with the the FDA?
(I am using continue here as we all know if a stop occurs what will happen)

3) I am thinking we will never hear an NCE decision as now the FDA has cause to delay more with a difference between Moss saying you do not have the power to change the meaning of moiety versus ingredient and now a DC judge saying they do have the ability to do such.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News